Gosset Ownership
Private
Employees
~14
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Neurotech Solutions General Information
Neurotech Solutions has developed the clinically validated MOXO Analytics Platform—a cloud-based digital tool used worldwide by clinicians to objectively assess attention profiles and support the diagnosis of ADHD. The platform provides measurable metrics on cognitive function using advanced analytics with unique distractor paradigms. It is ISO 13485 certified and supported by EU Horizon 2020 funding. The company’s solutions are widely adopted in clinical practice for both children and adults suspected of having attention disorders.
Contact Information
Primary Industry
Digital Health Medical Devices
Corporate Office
Ness Ziona, Central District
Israel
Israel
Drug Pipeline
No pipeline data available
Key Partnerships
European Union Horizon 2020 research grant, academic collaborations with psychiatry experts such as Prof. César Soutullo at UT Health Science Center Houston
Neurotech Solutions Funding
No funding data available
To view Neurotech Solutions's complete valuation and funding history, request access »